Status:
UNKNOWN
Trial Using 125I Embedded Stent in Patients With Advanced Esophageal Cancer
Lead Sponsor:
Southeast University, China
Conditions:
Esophageal Cancer
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
More than half of patients with esophageal cancer are inoperable because of late stage cancer or metastasis and they have to undergo palliative treatments. Dysphagia is the major symptom of patients w...
Detailed Description
Esophageal cancer ranks as the fourth leading cause of death from cancer in China and sixth worldwide. Although the prognosis of surgical resection for esophageal cancer has been improved, more than 5...
Eligibility Criteria
Inclusion
- Histologically confirmed primary cancer of esophagus,
- Must be dysphagia caused by esophageal cancer,
- Without esophageal fistulas,
- Must be an inpatient,
- Life expectancy is over 6 months
Exclusion
- Esophageal fistulas,
- Tracheal compression with symptoms,
- WBC \<2000/mm3 and Platelet count \<50,000/mm3,
- Concurrent therapies after stenting:surgery, chemotherapy,radiotherapy, Traditional Chinese Medicine
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00826813
Start Date
January 1 2009
End Date
March 1 2011
Last Update
January 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
#87 Dingjiaqiao Road
Nanjing, Jiangsu, China, 210009